Matteo Sebastiano-Rossi
Bern, BE 3010, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Targeting PI3Kδ suppresses pancreatic cancer by dual disruption of fibrosis and immune evasion.
Journal: Cell reports
Published: May 19, 2026
Targeting PI3Kδ suppresses pancreatic cancer by dual disruption of fibrosis and immune evasion.
Journal: Cell reports
Published: May 19, 2025
ACSL3-PAI-1 signaling axis mediates tumor-stroma cross-talk promoting pancreatic cancer progression.
ACSL3-PAI-1 signaling axis mediates tumor-stroma cross-talk promoting pancreatic cancer progression.
Journal: Science advances
Published: March 26, 2020
Author Correction: Modeling ErbB2-p130Cas interaction to design new potential anticancer agents.
Journal: Scientific reports
Published: November 24, 2019
The ACSL3-LPIAT1 signaling drives prostaglandin synthesis in non-small cell lung cancer.
Journal: Oncogene
Published: September 25, 2019
Targeting Long Chain Acyl-CoA Synthetases for Cancer Therapy.
Journal: International journal of molecular sciences
Published: June 28, 2019
PLCγ1 suppression promotes the adaptation of KRAS-mutant lung adenocarcinomas to hypoxia.
Journal: Nature cell biology
Published: June 27, 2019
Modeling ErbB2-p130Cas interaction to design new potential anticancer agents.
Journal: Scientific reports
Published: July 20, 2018
Impact of Dynamically Exposed Polarity on Permeability and Solubility of Chameleonic Drugs Beyond the Rule of 5.
Journal: Journal of medicinal chemistry
Published: April 03, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026